Phenomics Health Inc.

1600 Huron Parkway, Building 520, 2nd Floor   

Ann Arbor, MI  48109-2590

info@phenomicshealth.com

734-961-7211

Website designed by BrandHrt SMC | www.brandhrt.com

Phenomics Leadership Team

James S. Burns, DLS, MS, MBA, Co-Founder, Chairman & President Served previously as Chairman, President & CEO of Assurex Health, Inc., a precision medicine company focused on treatment decision support products for patients with neuropsychiatric and pain disorders.  Dr. Burns has extensive experience as a founder, senior executive, and venture capitalist in translational research, development and commercialization of life sciences technology, including novel pharmaceuticals, stem cells, genetic therapy, monoclonal antibodies, flow cytometry, DNA sequencing, cancer drug development, tissue transplantation, and pharmacogenomics.

Brian D. Athey, Ph.D., FACMI; Co-Founder, Director, Chief Science and Technology Officer - Serves as the Michael Savageau Collegiate Professor and Chair of the Department of Computational Medicine and Bioinformatics (DCMB), Professor of Psychiatry, and of Internal Medicine at the University of Michigan Medical School. Founding Co-Director of the Michigan Institute for Data Science (MIDAS), Dr. Athey also serves as a special advisor for life and health sciences to the Academic VP/Provost of the Chinese University Hong Kong Shenzhen (CUHK-SZ) and is a Fellow of the Shenzhen Research Institute for Big Data (SRIBD). 

Gilbert S. Omenn, M.D., Ph.D, Director and Chair, Scientific Advisory Board (SAB) - The Harold T. Shapiro Distinguished University Professor of Computational Medicine and Bioinformatics, Internal Medicine, Human Genetics, and Public Health at the University of Michigan. He served previously as the Chief Executive Officer of the University of Michigan System, Dean of Public Health at the University of Washington, and was a longtime board director of Amgen.  He has also served as associate director of the White House Office of Science and Technology Policy (OSTP), and is a long-standing member of the National Academy of Medicine. Dr. Omenn's research interests focus on differential expression of alternative splice isoforms of proteins and transcripts.